There may be some truth to the saying "the eyes are the window to the soul." Age-related changes are reflected in the retina, ...

Ocugen, Inc., a biotechnology company focused on gene therapies for blindness diseases, announced updates to its Retina Scientific Advisory Board and Executive Leadership Team. These changes are ...

EyeBio doubles the size of its original Series A raise with an additional $65 million, with new investors Bain Capital Life Sciences, Omega Funds and Vertex Ventures HC joining the round to support ...

Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply of nutrients and oxygen in the densely packed tissues is limited, leading to ...

Agreement includes up to $155 million in non-dilutive funding with an upfront payment of $35 million and a $5 million equity investment -- ...

The condition of the eye’s retina, and in particular the measure of retinal thickness (influenced by factors such as the amount of vascularization, atrophy, ischemic damage, and the presence or ...

The more precisely we want to examine the human retina, the more clearly one of the fundamental limits of physics becomes apparent. In cellular-resolution eye imaging, the same tradeoff has applied ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Therini Bio, Inc., a biotech company aimed at developing fibrin-targeted therapies to treat inflammatory neurodegenerative and retinal diseases, today ...

LAS VEGAS, June 4, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company ...

BIO Capital continues support as founding investor, having backed Ray Therapeutics since seed funding in 2021 through Series ...